These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35862218)

  • 1. ARMC5-CUL3 E3 ligase targets full-length SREBF in adrenocortical tumors.
    Okuno Y; Fukuhara A; Otsuki M; Shimomura I
    JCI Insight; 2022 Aug; 7(16):. PubMed ID: 35862218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cullin 3 targets the tumor suppressor gene ARMC5 for ubiquitination and degradation.
    Cavalcante IP; Vaczlavik A; Drougat L; Lotfi CFP; Perlemoine K; Ribes C; Rizk-Rabin M; Clauser E; Fragoso MCBV; Bertherat J; Ragazzon B
    Endocr Relat Cancer; 2020 Apr; 27(4):221-230. PubMed ID: 32023208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel germline ARMC5 mutation in a patient with bilateral macronodular adrenal hyperplasia: a case report.
    Liu Q; Tong D; Xu J; Yang X; Yi Y; Zhang D; Wang L; Zhang J; Zhang Y; Li Y; Chang L; Chen R; Guan Y; Yi X; Jiang J
    BMC Med Genet; 2018 Mar; 19(1):49. PubMed ID: 29587644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia.
    Lao L; Bourdeau I; Gagliardi L; He X; Shi W; Hao B; Tan M; Hu Y; Peng J; Coulombe B; Torpy DJ; Scott HS; Lacroix A; Luo H; Wu J
    Nucleic Acids Res; 2022 Jun; 50(11):6343-6367. PubMed ID: 35687106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia.
    Gagliardi L; Schreiber AW; Hahn CN; Feng J; Cranston T; Boon H; Hotu C; Oftedal BE; Cutfield R; Adelson DL; Braund WJ; Gordon RD; Rees DA; Grossman AB; Torpy DJ; Scott HS
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1784-92. PubMed ID: 24905064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation.
    Faucz FR; Zilbermint M; Lodish MB; Szarek E; Trivellin G; Sinaii N; Berthon A; Libé R; Assié G; Espiard S; Drougat L; Ragazzon B; Bertherat J; Stratakis CA
    J Clin Endocrinol Metab; 2014 Jun; 99(6):E1113-9. PubMed ID: 24601692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma.
    Elbelt U; Trovato A; Kloth M; Gentz E; Finke R; Spranger J; Galas D; Weber S; Wolf C; König K; Arlt W; Büttner R; May P; Allolio B; Schneider JG
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E119-28. PubMed ID: 25279498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of oxidative stress, glucocorticoid receptor and ARMC5 in lipid metabolism.
    Okuno Y; Fukuhara A; Shimomura I
    Endocr J; 2024 Jun; ():. PubMed ID: 38925988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New pathogenic variants in ARMC5 gene in a series of Italian patients affected by primary bilateral macronodular adrenocortical hyperplasia (PBMAH).
    Giacché M; Panarotto A; Mori L; Poliani PL; Lanzi R; Lena MS; Castellano M
    Mol Genet Genomic Med; 2023 Apr; 11(4):e2126. PubMed ID: 36727580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do patients with incidentally discovered bilateral adrenal nodules represent an early form of ARMC5-mediated bilateral macronodular hyperplasia?
    Emms H; Tsirou I; Cranston T; Tsagarakis S; Grossman AB
    Endocrine; 2016 Sep; 53(3):801-8. PubMed ID: 27306888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GERMLINE DELETION OF ARMC5 IN FAMILIAL PRIMARY MACRONODULAR ADRENAL HYPERPLASIA.
    Suzuki S; Tatsuno I; Oohara E; Nakayama A; Komai E; Shiga A; Kono T; Takiguchi T; Higuchi S; Sakuma I; Nagano H; Hashimoto N; Mayama T; Koide H; Sasano H; Nakatani Y; Imamoto T; Ichikawa T; Yokote K; Tanaka T
    Endocr Pract; 2015 Oct; 21(10):1152-60. PubMed ID: 26214113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological Harbingers of ARMC5-Pathogenic Variant-Related Bilateral Macronodular Adrenocortical Disease.
    de Arruda Botelho MLA; Nishi MY; Ribeiro KB; Zerbini MCN
    Endocr Pathol; 2023 Jun; 34(2):200-212. PubMed ID: 37043100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome.
    Assié G; Libé R; Espiard S; Rizk-Rabin M; Guimier A; Luscap W; Barreau O; Lefèvre L; Sibony M; Guignat L; Rodriguez S; Perlemoine K; René-Corail F; Letourneur F; Trabulsi B; Poussier A; Chabbert-Buffet N; Borson-Chazot F; Groussin L; Bertagna X; Stratakis CA; Ragazzon B; Bertherat J
    N Engl J Med; 2013 Nov; 369(22):2105-14. PubMed ID: 24283224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia.
    Yu L; Zhang J; Guo X; Chen X; He Z; He Q
    PLoS One; 2018; 13(1):e0191602. PubMed ID: 29370219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ARMC5 gene shows extensive genetic variance in primary macronodular adrenocortical hyperplasia.
    Correa R; Zilbermint M; Berthon A; Espiard S; Batsis M; Papadakis GZ; Xekouki P; Lodish MB; Bertherat J; Faucz FR; Stratakis CA
    Eur J Endocrinol; 2015 Oct; 173(4):435-40. PubMed ID: 26162405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent effects of Armc5 haploinsufficiency on adrenocortical function.
    Berthon A; Faucz FR; Espiard S; Drougat L; Bertherat J; Stratakis CA
    Hum Mol Genet; 2017 Sep; 26(18):3495-3507. PubMed ID: 28911199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary bilateral macronodular adrenocortical hyperplasia (PBMAH) patient with ARMC5 mutations.
    Tang P; Zhang J; Peng S; Yan X; Wang Y; Wang S; Zhang Y; Liu G; Xu J; Huang Y; Zhang D; Liu Q; Jiang J; Lan W
    BMC Endocr Disord; 2023 Apr; 23(1):77. PubMed ID: 37029354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARMC5 mutations in a large French-Canadian family with cortisol-secreting β-adrenergic/vasopressin responsive bilateral macronodular adrenal hyperplasia.
    Bourdeau I; Oble S; Magne F; Lévesque I; Cáceres-Gorriti KY; Nolet S; Awadalla P; Tremblay J; Hamet P; Fragoso MC; Lacroix A
    Eur J Endocrinol; 2016 Jan; 174(1):85-96. PubMed ID: 26604299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions.
    Mulatero P; Schiavi F; Williams TA; Monticone S; Barbon G; Opocher G; Fallo F
    J Hum Hypertens; 2016 Jun; 30(6):374-8. PubMed ID: 26446392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1).
    Damjanovic SS; Antic JA; Elezovic-Kovacevic VI; Dundjerovic DM; Milicevic IT; Beleslin-Cokic BB; Ilic BB; Rodic GS; Berthon A; Maria AG; Faucz FR; Stratakis CA
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4531-42. PubMed ID: 32901291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.